Wealthcare Advisory Partners LLC lowered its stake in MetLife, Inc. (NYSE:MET - Free Report) by 33.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 5,920 shares of the financial services provider's stock after selling 3,001 shares during the period. Wealthcare Advisory Partners LLC's holdings in MetLife were worth $485,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of MET. MeadowBrook Investment Advisors LLC boosted its position in shares of MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock worth $26,000 after acquiring an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. boosted its holdings in shares of MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock valued at $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC increased its stake in shares of MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock valued at $29,000 after purchasing an additional 277 shares during the last quarter. Peterson Financial Group Inc. acquired a new position in shares of MetLife during the 3rd quarter worth $30,000. Finally, Fortitude Family Office LLC boosted its stake in MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider's stock valued at $34,000 after buying an additional 266 shares in the last quarter. 94.99% of the stock is owned by institutional investors.
MetLife Stock Performance
NYSE:MET traded up $0.08 on Tuesday, reaching $86.86. 1,479,585 shares of the company's stock were exchanged, compared to its average volume of 3,402,039. The stock has a fifty day simple moving average of $83.51 and a 200-day simple moving average of $79.66. MetLife, Inc. has a 52 week low of $64.61 and a 52 week high of $89.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The firm has a market cap of $60.14 billion, a price-to-earnings ratio of 17.54, a P/E/G ratio of 0.64 and a beta of 1.07.
MetLife Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.51%. The ex-dividend date is Tuesday, February 4th. MetLife's dividend payout ratio is 43.95%.
Analysts Set New Price Targets
MET has been the topic of a number of research analyst reports. Barclays raised their price target on shares of MetLife from $90.00 to $96.00 and gave the company an "overweight" rating in a research note on Monday, January 6th. StockNews.com cut MetLife from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Wells Fargo & Company reduced their price target on MetLife from $93.00 to $92.00 and set an "overweight" rating on the stock in a report on Tuesday, January 14th. Piper Sandler lifted their target price on shares of MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a research report on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. upped their price target on shares of MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a research report on Tuesday, January 7th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $89.92.
Check Out Our Latest Report on MetLife
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.